Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials
Inflammatory Bowel Diseases · 01.08.2026 · 32 (8) · 1644-1648
DOI: 10.1093/ibd/izag054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 04.04.2026. Verfasst von Emily C L Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Can…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Biological Products, Janus Kinase Inhibitors. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Older adults with ulcerative colitis (UC) are often undertreated with advanced therapies due to safety concerns. We evaluated whether outcomes differ by age in randomized trials.
Methods
Post hoc analysis of 2841 participants from 13 UC induction trials of biologics and JAK inhibitors compared efficacy (patient-reported outcomes 2 response/remission, clinical remission, endoscopic improvement) and safety between patients ≥60 years of age vs <60 years of age.
Results
Efficacy and safety outcomes were similar across age groups, with minor therapy-specific variation. Hospitalization was numerically higher in older adults.
Conclusions
Advanced therapies show comparable efficacy and safety in UC regardless of age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
- Division of Gastroenterology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, ON, Canada.
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Emily C L Wong, Christopher Ma, Walter Reinisch, Neeraj Narula
Zitieren
APA
Wong, E. C. L., Marshall, J. K., Ma, C., Jairath, V., Reinisch, W., & Narula, N. (2026). Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials. Inflammatory Bowel Diseases, 32(8), 1644-1648. https://doi.org/10.1093/ibd/izag054
Vancouver
Wong ECL, Marshall JK, Ma C, Jairath V, Reinisch W, Narula N. Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials. Inflammatory Bowel Diseases. 2026;32(8):1644-1648. doi:10.1093/ibd/izag054
BibTeX
@article{Wong2026,
author = {Wong, Emily C L and Marshall, John K and Ma, Christopher and Jairath, Vipul and Reinisch, Walter and Narula, Neeraj},
title = {Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials},
journal = {Inflammatory Bowel Diseases},
year = {2026},
volume = {32},
number = {8},
pages = {1644--1648},
doi = {10.1093/ibd/izag054}
}
EUVIMED